Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is designed to evaluate the safety, tolerability, and pharmacokinetics of HX-1171 in healthy male subjects.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HX-1171 20 mg (20mg 1T) | Experimental |
| |
| HX-1171 40 mg (20mg 2T) | Experimental |
| |
| HX-1171 80 mg (20mg 4T) | Experimental |
| |
| HX-1171 160 mg (20mg 8T) | Experimental |
| |
| HX-1171 300 mg (200mg 1T, 20mg 5T) | Experimental |
| |
| HX-1171 600 mg (200mg 3T) | Experimental |
| |
| HX-1171 1200 mg (500mg 2T, 200mg 1T) | Experimental |
| |
| HX-1171 1500 mg (500mg 3T) |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HX-1171 | Drug | 20mg, 200mg, 500mg |
|
| Measure | Description | Time Frame |
|---|---|---|
| Safety (normal results for safety tests) | Physical examination, Vital signs | 14days |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Asan Medical Center | Seoul | South Korea |
Not provided
| Label | URL |
|---|---|
| Clinical Research Center, Asan Medical Center | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| C081906 | 1-O-hexyl-2,3,5-trimethylhydroquinone |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| HX-1171 2000 mg (500mg 4T) | Experimental |
|